Houlihan Lokey Advises Pentec Health

Houlihan Lokey is pleased to announce that Pentec Health Inc., a portfolio company of Norwest Equity Partners (NEP), has been acquired by Wellspring Capital Management LLC (Wellspring).

Founded in 1983 and based in Glen Mills, Pennsylvania, Pentec Health has been an industry leader in providing patient-specific, compounded sterile medications. Pentec Health’s formulations are used for administration in dialysis centers as well as providing in-home targeted drug delivery through nursing services and complex pharmaceutical products to patients who require access outside of a hospital setting. Pentec Health has built a tradition of exceptional patient care by committing to quality, safety, and innovation. Pentec Health aims to be the provider of choice for outsourced products, sterile preparations, and services in the healthcare marketplace.

Founded in 1961, NEP is a leading middle-market investment firm with offices in Minneapolis and West Palm Beach, Florida. NEP invests equity capital in companies that are leaders in their industries with a proven business model that has demonstrated the ability to generate profits. NEP has extensive experience across a range of industries with management buyouts, recapitalizations, and growth financings, including working with founder- and family-owned companies.

Wellspring Capital Management is a leading private equity firm headquartered in New York. Since its founding in 1995, Wellspring has raised over $4.5 billion of initial capital commitments through six private equity funds. In total, Wellspring’s current portfolio companies employ nearly 60,000 people around the world and generated aggregate revenues in excess of approximately $4.5 billion in the past 12 months. Over the past 25 years, Wellspring has invested in over 45 platform investments across various segments of the U.S. and global economies. Wellspring’s objective is to bring partnership, experience, and value creation to each investment. By teaming up with strong management, Wellspring seeks to unlock underlying value and pursue new growth opportunities through strategic initiatives, operating improvements, and add‐on acquisitions. The firm functions as a strategic partner, providing management teams with top‐line support, M&A experience, financial expertise, and access to resources.

Houlihan Lokey served as the financial advisor to Pentec Health and assisted in initiating, structuring, and negotiating the transaction on its behalf.

This transaction further strengthens Houlihan Lokey’s leadership position in the infusion services sector. Houlihan Lokey’s Healthcare Group is among the largest dedicated healthcare investment banking groups in the country. In 2020, the group closed 22 transactions and was ranked the No. 1 advisor for U.S. healthcare M&A transactions under $1 billion by Refinitiv. Houlihan Lokey’s Healthcare Group has closed more than 300 M&A healthcare transactions since inception.